BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
Qbiogene s goal is to become a leading provider of a fully integrated offering of research products and comprehensive customized service solutions serving the needs of pharmaceutical and biotechnology companies from the early phases of their basic research through to the final stages of their clinical trials. Qbiogene has recognized that the enormous growth in biotechnology research is forcing companies to outsource. In addition insufficient manufacturing capacity is also a problem. Qbiogene can take advantage of these trends by offering research companies the possibility of outsourcing complete processes from initial research to laboratory testing to manufacturing. In this way Qbiogene can leverage its expertise to generate repeat business and create a well-diversified revenue base. This gives the company a unique selling position in what is otherwise a highly fragmented industry. This is the basis of the company s strategy...
Number of Employees 74
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
News & Analysis
Filter by
qbiogene inc. - All News and Analysis
Biotechnology Research Institute of NRC And Qbiogene Announce $3.8 Million Collaboration.
- 2001-09-10
MONTREAL, QUEBEC, SEPTEMBER 10, 2001 The Biotechnology Research Institute BRI of the National Research Council of Canada NRC and Qbiogene Inc. announce a $3.8 million collaborative research project for the development of adenoviral libraries and associated reagents, in which BRI shares the associated ...
Qbiogene Announces Strategic Licensing Agreement with Glaxo Wellcome.
- 2000-08-11
MONTREAL, Aug 09, 2000 Qbiogene, a global leader in the development of research technology, has signed an agreement with Glaxo Wellcome Inc. that will enhance the development of new tools used in genomics research. Under the terms of this agreement, Qbiogene will develop a...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
